| Authors: |
Shepard ER; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Wegner A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Hill EV; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Burton BR; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Aerts S; Apitope International NV, Diepenbeek, Belgium., Schurgers E; Apitope International NV, Diepenbeek, Belgium., Hoedemaekers B; Apitope International NV, Diepenbeek, Belgium., Ng STH; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Streeter HB; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Jansson L; Apitope International NV, Diepenbeek, Belgium., Wraith DC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom. |